Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2007 2
2008 3
2009 6
2010 3
2011 1
2012 7
2013 6
2014 6
2015 8
2016 7
2017 6
2018 8
2019 5
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
Lazzarini E, Silvestris DA, Benvenuto G, Osti D, Fattore L, Paterra R, Finocchiaro G, Malatesta P, Daga A, Gallotti AL, Galli R, Pelicci G, Tesei A, Bedeschi M, Pallini R, Pasqualini L, Romualdi C, Gallo A, Ricci-Vitiani L, Indraccolo S. Lazzarini E, et al. Among authors: daga a. J Neurooncol. 2023 May;163(1):47-59. doi: 10.1007/s11060-023-04287-6. Epub 2023 May 4. J Neurooncol. 2023. PMID: 37140883 Free PMC article.
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: daga a. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.
Ultra-hyper-fractionated radiotherapy for high-grade gliomas.
Frosina G, Fontana V, Verzola D, Rosa A, Gaggero G, Garibotto G, Vagge S, Pigozzi S, Daga A. Frosina G, et al. Among authors: daga a. J Neurosci Res. 2021 Dec;99(12):3182-3203. doi: 10.1002/jnr.24929. Epub 2021 Nov 8. J Neurosci Res. 2021. PMID: 34747065
Ligand-targeted liposomal therapies of neuroblastoma.
Pastorino F, Marimpietri D, Brignole C, Di Paolo D, Pagnan G, Daga A, Piccardi F, Cilli M, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: daga a. Curr Med Chem. 2007;14(29):3070-8. doi: 10.2174/092986707782793916. Curr Med Chem. 2007. PMID: 18220743 Review.
New perspectives in glioma immunotherapy.
Daga A, Bottino C, Castriconi R, Gangemi R, Ferrini S. Daga A, et al. Curr Pharm Des. 2011;17(23):2439-67. doi: 10.2174/138161211797249206. Curr Pharm Des. 2011. PMID: 21827420 Review.
Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.
Liguori L, Pastorino F, Rousset X, Alfano S, Cortes S, Emionite L, Daga A, Ponzoni M, Lenormand JL. Liguori L, et al. Among authors: daga a. Molecules. 2015 Sep 1;20(9):15893-909. doi: 10.3390/molecules200915893. Molecules. 2015. PMID: 26340616 Free PMC article.
73 results